Nanomaterials In Personalized Medicine Market, By Application Areas, By End-users, By Type of Nanomaterials, By Technology Utilized, By Formulation Type, By Country, and By Region – Global Industry Analysis, Market Size, Market Share & Forecast from 2025-
Description
REPORT HIGHLIGHT
The Nanomaterials In Personalized Medicine Market size was valued at US$ 355,456.34 Million in 2024, expanding at a CAGR of 11.5% from 2025 to 2032.
Nanomaterials in personalized medicine are nanoscale-engineered substances that interact with biological systems in a precise and controlled manner, allowing healthcare interventions to be tailored to an individual's specific genetic, molecular, or physiological characteristics. The rising prevalence of chronic diseases and advances in nanotechnology are major motivators, but high development costs and regulatory hurdles are significant impediments. However, opportunities exist for the development of novel nanomaterials with improved properties, the use of AI in drug discovery, and expansion into emerging markets. Strategic collaborations between pharmaceutical companies, biotechnology firms, and academic institutions are critical for overcoming these obstacles and realizing market potential.
Nanomaterials In Personalized Medicine Market- Market Dynamics
Increasing Demand for Personalized Medicine Fueling the Market Growth
The rising demand for personalized medicine is expected to drive the growth of nanomaterials in the personalized medicine market in the coming years. Personalized medicine is a medical approach in which treatments are tailored to individual patients based on genetic, environmental, and lifestyle factors in order to optimize outcomes and improve care. The demand for personalized medicine is growing as genomic technologies advance, allowing for the precise identification of genetic variations and tailored treatments for individuals. Nanomaterials improve personalized medicine by allowing for targeted and patient-specific therapies, which improves treatment efficacy and safety. They enable targeted delivery of drugs, genes, or RNA, lowering side effects and improving therapeutic outcomes. According to the Personalized Medicine Coalition (PMC), a nonprofit organization based in the United States, the FDA approved 26 new personalized medicines in 2023, up from 12 in 2022. As a result, the growing demand for personalized medicine is driving the development of nanomaterials in the personalized medicine industry.
Nanomaterials In Personalized Medicine Market- Segmentation Analysis:
The worldwide market is segmented on the basis of Application Areas, End-users, Type of Nanomaterials, Technology Utilized, Formulation Type, and Region.
The Formulation Type segment is primarily categorized into Nanoparticles, Nanocrystals, Nanosuspensions, Nanoemulsions, and Nanoformulations for Targeted Delivery. Among which. Nanoparticles are a crucial segment in the nanomaterials market for personalized medicine, playing a vital role in targeted drug delivery, cancer treatment and diagnostics. Their ability to overcome biological barriers and deliver therapeutic agents precisely to diseased cells makes them an attractive solution for various medical applications. For instance, in April 2025, Marama Labs launched CloudSpec, an instrument that accelerates quantification of drug payloads in lipid nanoparticles, enabling precise RNA or DNA measurements within 15 seconds.
Based on Application Areas, Drug Delivery Systems are one of the most important segments of the Nanomaterials in Personalized Medicine market because nano-enabled carriers (particularly lipid nanoparticles, or LNPs) enable the precise, safe, and efficient delivery of personalized therapies—including mRNA, siRNA, and gene-editing agents—to the intended cells while protecting fragile nucleic acids and minimizing off-target effects. One compelling example is Acuitas Therapeutics, a pioneer in LNP delivery technology. At the ASGCT annual meeting in 2025, Acuitas presented preclinical data for next-generation LNPs with DARPin-conjugated ligands to direct mRNA payloads to T-cells, as well as repeat dosing safety and targeting beyond the liver. In May 2024, Aldevron announced a strategic partnership with Acuitas to deploy its LNP platform for mRNA sequence-to-vial manufacturing, significantly increasing capacity for personalized RNA therapies.
Nanomaterials In Personalized Medicine Market- Geographical Insights
Asia Pacific has a significant share of the Nanomaterials in personalized medicine Market, owing to strong government initiatives, expanding biotech infrastructure, and increased healthcare investment. Countries such as China, India, Japan, and South Korea are at the forefront, with national programs supporting nanotechnology research and precision medicine development. Rising disease prevalence, particularly in chronic and genetic conditions, drives up demand for personalized nanomedicines. The region's growing middle class, combined with improved access to advanced healthcare, promotes the use of nano-enabled diagnostics and therapeutics. Asia Pacific is becoming a key market for innovation and growth, with rapid expansion in R&D and commercial capacity.
Japan Nanomaterials In Personalized Medicine Market- Country Insights
Japan is emerging as a major hub for nanomedicine innovation, due to strong government R&D support and a well-established biotech infrastructure. The Japan Nanomedicine Society encourages collaboration among academia, industry, and healthcare to advance nanomaterial-based therapies for personalized medicine. In April 2024, Nanoform Finland formed a strategic partnership with Japanese pharmaceutical firm CBC Co., Ltd. to bring Nanoform's nanoparticle-engineering platform to Japan. The goal is to improve drug bioavailability and reduce doses for Japanese patients. Furthermore, the Innovation Center of NanoMedicine (iCONM) in Kawasaki is spearheading cutting-edge research: in mid-2025, a team of researchers developed a nanomedicine that delivers antisense nucleic acids to lymph nodes to suppress cancer metastases.
Nanomaterials In Personalized Medicine Market- Competitive Landscape:
The competitive landscape for Nanomaterials in Personalized Medicine Market is moderately concentrated, with major players including Evonik Industries AG, OncoNano Medicine Inc., and Merck KGaA. Evonik is developing lipid-based nanocarriers for cancer treatments, whereas OncoNano Medicine focuses on gold nanoparticle platforms for precise drug delivery and imaging. Merck KGaA uses polymer-based nanomaterials for targeted gene therapy and personalized prophylactics. These companies compete to improve nanocarriers' biocompatibility, stability, and targeting capabilities. Strategic partnerships, clinical collaborations, and scale-up initiatives all contribute to innovation. As the demand for tailored treatments grows, companies prioritize R&D investment and commercialization strategies to maintain their position as leaders in precision nanomedicine.
Recent Developments:
In June 2023, Bayer AG, a German pharmaceutical and biotechnology company, has partnered with Acuitas Therapeutics Inc. to gain access to its lipid nanoparticle (LNP) delivery technology. This collaboration aims to advance Bayer's in vivo gene editing and protein replacement programs by utilizing Acuitas' lipid nanoparticle technology, which enables efficient and targeted RNA delivery, particularly to the liver. Acuitas Therapeutics Inc. is a Canadian biotechnology company that specializes in lipid nanoparticle (LNP) delivery systems, which are important nanomaterials for personalized medicine.
In September 2023, Evonik improved its parenteral drug delivery solutions with three new PLA-PEG di-block copolymers (RESOMER RP d) and a nanoparticle formulation service based on sonication technology. The copolymers are excellent for nanoparticle formation and controlled drug release applications. The new nanosonication process allows for cGMP production of nanoparticles, addressing production challenges in drug delivery.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Merck KGaA Darmstadt Germany
OncoNano Medicine Inc.
Molecular Rebar Design Inc
Cello Therapeutics Inc.
Evonik Industries AG
Eisai Co. Ltd.
TÜV Rheinland AG
OCSiAl S.A
Sanofi S.A.
The Bristol-Myers Squibb Company
Thermo Fisher Scientific Inc.
Abbott Laboratories
American Elements Inc.
Pfizer & Co. Inc
BASF SE
Cour Pharmaceuticals Inc.
Nanocomposix Inc
NoPo Nanotechnologies Private Limited
Matexcel Biotech Inc.
Apurano Pharmaceuticals GmbH
SGN Nanopharma Inc.
Others
GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY APPLICATION AREAS- MARKET ANALYSIS, 2019 - 2032
Drug Delivery Systems
Regenerative Medicine
Diagnostics and Imaging
Therapeutics
Vaccines
GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY END-USERS- MARKET ANALYSIS, 2019 - 2032
Hospitals & Clinics
Biotechnology Firms
Academic Institutions
Research Laboratories
Pharmaceutical Companies
GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY TYPE OF NANOMATERIALS- MARKET ANALYSIS, 2019 - 2032
Carbon-based Nanomaterials
Nanostructured Materials
Metallic Nanoparticles
Polymeric Nanomaterials
Silica Nanoparticles
GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY TECHNOLOGY UTILIZED- MARKET ANALYSIS, 2019 - 2032
Nanofabrication Techniques
Molecular Imaging Techniques
Nanotechnology-based Screening Methods
Bioconjugation Methods
Surface Modification Techniques
GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY FORMULATION TYPE- MARKET ANALYSIS, 2019 - 2032
Nanoparticles
Nanocrystals
Nanosuspensions
Nanoemulsions
Nanoformulations for Targeted Delivery
GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA
The Nanomaterials In Personalized Medicine Market size was valued at US$ 355,456.34 Million in 2024, expanding at a CAGR of 11.5% from 2025 to 2032.
Nanomaterials in personalized medicine are nanoscale-engineered substances that interact with biological systems in a precise and controlled manner, allowing healthcare interventions to be tailored to an individual's specific genetic, molecular, or physiological characteristics. The rising prevalence of chronic diseases and advances in nanotechnology are major motivators, but high development costs and regulatory hurdles are significant impediments. However, opportunities exist for the development of novel nanomaterials with improved properties, the use of AI in drug discovery, and expansion into emerging markets. Strategic collaborations between pharmaceutical companies, biotechnology firms, and academic institutions are critical for overcoming these obstacles and realizing market potential.
Nanomaterials In Personalized Medicine Market- Market Dynamics
Increasing Demand for Personalized Medicine Fueling the Market Growth
The rising demand for personalized medicine is expected to drive the growth of nanomaterials in the personalized medicine market in the coming years. Personalized medicine is a medical approach in which treatments are tailored to individual patients based on genetic, environmental, and lifestyle factors in order to optimize outcomes and improve care. The demand for personalized medicine is growing as genomic technologies advance, allowing for the precise identification of genetic variations and tailored treatments for individuals. Nanomaterials improve personalized medicine by allowing for targeted and patient-specific therapies, which improves treatment efficacy and safety. They enable targeted delivery of drugs, genes, or RNA, lowering side effects and improving therapeutic outcomes. According to the Personalized Medicine Coalition (PMC), a nonprofit organization based in the United States, the FDA approved 26 new personalized medicines in 2023, up from 12 in 2022. As a result, the growing demand for personalized medicine is driving the development of nanomaterials in the personalized medicine industry.
Nanomaterials In Personalized Medicine Market- Segmentation Analysis:
The worldwide market is segmented on the basis of Application Areas, End-users, Type of Nanomaterials, Technology Utilized, Formulation Type, and Region.
The Formulation Type segment is primarily categorized into Nanoparticles, Nanocrystals, Nanosuspensions, Nanoemulsions, and Nanoformulations for Targeted Delivery. Among which. Nanoparticles are a crucial segment in the nanomaterials market for personalized medicine, playing a vital role in targeted drug delivery, cancer treatment and diagnostics. Their ability to overcome biological barriers and deliver therapeutic agents precisely to diseased cells makes them an attractive solution for various medical applications. For instance, in April 2025, Marama Labs launched CloudSpec, an instrument that accelerates quantification of drug payloads in lipid nanoparticles, enabling precise RNA or DNA measurements within 15 seconds.
Based on Application Areas, Drug Delivery Systems are one of the most important segments of the Nanomaterials in Personalized Medicine market because nano-enabled carriers (particularly lipid nanoparticles, or LNPs) enable the precise, safe, and efficient delivery of personalized therapies—including mRNA, siRNA, and gene-editing agents—to the intended cells while protecting fragile nucleic acids and minimizing off-target effects. One compelling example is Acuitas Therapeutics, a pioneer in LNP delivery technology. At the ASGCT annual meeting in 2025, Acuitas presented preclinical data for next-generation LNPs with DARPin-conjugated ligands to direct mRNA payloads to T-cells, as well as repeat dosing safety and targeting beyond the liver. In May 2024, Aldevron announced a strategic partnership with Acuitas to deploy its LNP platform for mRNA sequence-to-vial manufacturing, significantly increasing capacity for personalized RNA therapies.
Nanomaterials In Personalized Medicine Market- Geographical Insights
Asia Pacific has a significant share of the Nanomaterials in personalized medicine Market, owing to strong government initiatives, expanding biotech infrastructure, and increased healthcare investment. Countries such as China, India, Japan, and South Korea are at the forefront, with national programs supporting nanotechnology research and precision medicine development. Rising disease prevalence, particularly in chronic and genetic conditions, drives up demand for personalized nanomedicines. The region's growing middle class, combined with improved access to advanced healthcare, promotes the use of nano-enabled diagnostics and therapeutics. Asia Pacific is becoming a key market for innovation and growth, with rapid expansion in R&D and commercial capacity.
Japan Nanomaterials In Personalized Medicine Market- Country Insights
Japan is emerging as a major hub for nanomedicine innovation, due to strong government R&D support and a well-established biotech infrastructure. The Japan Nanomedicine Society encourages collaboration among academia, industry, and healthcare to advance nanomaterial-based therapies for personalized medicine. In April 2024, Nanoform Finland formed a strategic partnership with Japanese pharmaceutical firm CBC Co., Ltd. to bring Nanoform's nanoparticle-engineering platform to Japan. The goal is to improve drug bioavailability and reduce doses for Japanese patients. Furthermore, the Innovation Center of NanoMedicine (iCONM) in Kawasaki is spearheading cutting-edge research: in mid-2025, a team of researchers developed a nanomedicine that delivers antisense nucleic acids to lymph nodes to suppress cancer metastases.
Nanomaterials In Personalized Medicine Market- Competitive Landscape:
The competitive landscape for Nanomaterials in Personalized Medicine Market is moderately concentrated, with major players including Evonik Industries AG, OncoNano Medicine Inc., and Merck KGaA. Evonik is developing lipid-based nanocarriers for cancer treatments, whereas OncoNano Medicine focuses on gold nanoparticle platforms for precise drug delivery and imaging. Merck KGaA uses polymer-based nanomaterials for targeted gene therapy and personalized prophylactics. These companies compete to improve nanocarriers' biocompatibility, stability, and targeting capabilities. Strategic partnerships, clinical collaborations, and scale-up initiatives all contribute to innovation. As the demand for tailored treatments grows, companies prioritize R&D investment and commercialization strategies to maintain their position as leaders in precision nanomedicine.
Recent Developments:
In June 2023, Bayer AG, a German pharmaceutical and biotechnology company, has partnered with Acuitas Therapeutics Inc. to gain access to its lipid nanoparticle (LNP) delivery technology. This collaboration aims to advance Bayer's in vivo gene editing and protein replacement programs by utilizing Acuitas' lipid nanoparticle technology, which enables efficient and targeted RNA delivery, particularly to the liver. Acuitas Therapeutics Inc. is a Canadian biotechnology company that specializes in lipid nanoparticle (LNP) delivery systems, which are important nanomaterials for personalized medicine.
In September 2023, Evonik improved its parenteral drug delivery solutions with three new PLA-PEG di-block copolymers (RESOMER RP d) and a nanoparticle formulation service based on sonication technology. The copolymers are excellent for nanoparticle formation and controlled drug release applications. The new nanosonication process allows for cGMP production of nanoparticles, addressing production challenges in drug delivery.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Merck KGaA Darmstadt Germany
OncoNano Medicine Inc.
Molecular Rebar Design Inc
Cello Therapeutics Inc.
Evonik Industries AG
Eisai Co. Ltd.
TÜV Rheinland AG
OCSiAl S.A
Sanofi S.A.
The Bristol-Myers Squibb Company
Thermo Fisher Scientific Inc.
Abbott Laboratories
American Elements Inc.
Pfizer & Co. Inc
BASF SE
Cour Pharmaceuticals Inc.
Nanocomposix Inc
NoPo Nanotechnologies Private Limited
Matexcel Biotech Inc.
Apurano Pharmaceuticals GmbH
SGN Nanopharma Inc.
Others
GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY APPLICATION AREAS- MARKET ANALYSIS, 2019 - 2032
Drug Delivery Systems
Regenerative Medicine
Diagnostics and Imaging
Therapeutics
Vaccines
GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY END-USERS- MARKET ANALYSIS, 2019 - 2032
Hospitals & Clinics
Biotechnology Firms
Academic Institutions
Research Laboratories
Pharmaceutical Companies
GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY TYPE OF NANOMATERIALS- MARKET ANALYSIS, 2019 - 2032
Carbon-based Nanomaterials
Nanostructured Materials
Metallic Nanoparticles
Polymeric Nanomaterials
Silica Nanoparticles
GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY TECHNOLOGY UTILIZED- MARKET ANALYSIS, 2019 - 2032
Nanofabrication Techniques
Molecular Imaging Techniques
Nanotechnology-based Screening Methods
Bioconjugation Methods
Surface Modification Techniques
GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY FORMULATION TYPE- MARKET ANALYSIS, 2019 - 2032
Nanoparticles
Nanocrystals
Nanosuspensions
Nanoemulsions
Nanoformulations for Targeted Delivery
GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA
Table of Contents
375 Pages
- 1. Nanomaterials In Personalized Medicine Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
- 2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Nanomaterials In Personalized Medicine Market Snippet by Application Areas
- 2.1.2. Nanomaterials In Personalized Medicine Market Snippet by End-users
- 2.1.3. Nanomaterials In Personalized Medicine Market Snippet by Type of Nanomaterials
- 2.1.4. Nanomaterials In Personalized Medicine Market Snippet by Technology Utilized
- 2.1.5. Nanomaterials In Personalized Medicine Market Snippet by Formulation Type
- 2.1.6. Nanomaterials In Personalized Medicine Market Snippet by Country
- 2.1.7. Nanomaterials In Personalized Medicine Market Snippet by Region
- 2.2. Competitive Insights
- 3. Nanomaterials In Personalized Medicine Key Market Trends
- 3.1. Nanomaterials In Personalized Medicine Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Nanomaterials In Personalized Medicine Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Nanomaterials In Personalized Medicine Market Opportunities
- 3.4. Nanomaterials In Personalized Medicine Market Future Trends
- 4. Nanomaterials In Personalized Medicine Industry Study
- 4.1. PEST Analysis
- 4.2. Porter’s Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
- 5. Nanomaterials In Personalized Medicine Market: Impact of Escalating Geopolitical Tensions
- 5.1. Impact of COVID-19 Pandemic
- 5.2. Impact of Russia-Ukraine War
- 5.3. Impact of Middle East Conflicts
- 6. Nanomaterials In Personalized Medicine Market Landscape
- 6.1. Nanomaterials In Personalized Medicine Market Share Analysis, 2024
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players’ Analysis
- 6.2.2. Emerging Players’ Analysis
- 7. Nanomaterials In Personalized Medicine Market – By Application Areas
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Application Areas, 2024 & 2032 (%)
- 7.1.2. Drug Delivery Systems
- 7.1.3. Regenerative Medicine
- 7.1.4. Diagnostics and Imaging
- 7.1.5. Therapeutics
- 7.1.6. Vaccines
- 8. Nanomaterials In Personalized Medicine Market – By End-users
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By End-users, 2024 & 2032 (%)
- 8.1.2. Hospitals & Clinics
- 8.1.3. Biotechnology Firms
- 8.1.4. Academic Institutions
- 8.1.5. Research Laboratories
- 8.1.6. Pharmaceutical Companies
- 9. Nanomaterials In Personalized Medicine Market – By Type of Nanomaterials
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Type of Nanomaterials, 2024 & 2032 (%)
- 9.1.2. Carbon-based Nanomaterials
- 9.1.3. Nanostructured Materials
- 9.1.4. Metallic Nanoparticles
- 9.1.5. Polymeric Nanomaterials
- 9.1.6. Silica Nanoparticles
- 10. Nanomaterials In Personalized Medicine Market – By Technology Utilized
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By End-users, 2024 & 2032 (%)
- 10.1.2. Nanofabrication Techniques
- 10.1.3. Molecular Imaging Techniques
- 10.1.4. Nanotechnology-based Screening Methods
- 10.1.5. Bioconjugation Methods
- 10.1.6. Surface Modification Techniques
- 11. Nanomaterials In Personalized Medicine Market – By Formulation Type
- 11.1. Overview
- 11.1.1. Segment Share Analysis, By Formulation Type, 2024 & 2032 (%)
- 11.1.2. Nanoparticles
- 11.1.3. Nanocrystals
- 11.1.4. Nanosuspensions
- 11.1.5. Nanoemulsions
- 11.1.6. Nanoformulations for Targeted Delivery
- 12. Nanomaterials In Personalized Medicine Market– By Geography
- 12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
- 12.2. North America
- 12.2.1. Overview
- 12.2.2. Nanomaterials In Personalized Medicine Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.2.9. U.S.
- 12.2.9.1. Overview
- 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.2.9.3. U.S. Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.2.9.4. U.S. Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.2.9.5. U.S. Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.2.9.6. U.S. Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.2.9.7. U.S. Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.2.10. Canada
- 12.2.10.1. Overview
- 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.2.10.3. Canada Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.2.10.4. Canada Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.2.10.5. Canada Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.2.10.6. Canada Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.2.10.7. Canada Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.3. Europe
- 12.3.1. Overview
- 12.3.2. Nanomaterials In Personalized Medicine Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.3.9. Germany
- 12.3.9.1. Overview
- 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.9.3. Germany Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.3.9.4. Germany Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.3.9.5. Germany Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.3.9.6. Germany Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.3.9.7. Germany Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.3.10. UK
- 12.3.10.1. Overview
- 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.10.3. UK Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.3.10.4. UK Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.3.10.5. UK Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.3.10.6. UK Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.3.10.7. UK Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.3.11. France
- 12.3.11.1. Overview
- 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.11.3. France Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.3.11.4. France Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.3.11.5. France Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.3.11.6. France Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.3.11.7. France Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.3.12. Italy
- 12.3.12.1. Overview
- 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.12.3. Italy Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.3.12.4. Italy Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.3.12.5. Italy Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.3.12.6. Italy Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.3.12.7. Italy Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.3.13. Spain
- 12.3.13.1. Overview
- 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.13.3. Spain Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.3.13.4. Spain Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.3.13.5. Spain Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.3.13.6. Spain Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.3.13.7. Spain Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.3.14. The Netherlands
- 12.3.14.1. Overview
- 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.14.3. The Netherlands Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.3.14.4. The Netherlands Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.3.14.5. The Netherlands Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.3.14.6. The Netherlands Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.3.14.7. The Netherlands Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.3.15. Sweden
- 12.3.15.1. Overview
- 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.15.3. Sweden Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.3.15.4. Sweden Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.3.15.5. Sweden Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.3.15.6. Sweden Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.3.15.7. Sweden Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.3.16. Russia
- 12.3.16.1. Overview
- 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.16.3. Russia Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.3.16.4. Russia Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.3.16.5. Russia Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.3.16.6. Russia Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.3.16.7. Russia Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.3.17. Poland
- 12.3.17.1. Overview
- 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.17.3. Poland Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.3.17.4. Poland Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.3.17.5. Poland Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.3.17.6. Poland Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.3.17.7. Poland Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.3.18. Rest of Europe
- 12.3.18.1. Overview
- 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.18.3. Rest of the Europe Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.3.18.4. Rest of the Europe Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.3.18.5. Rest of the Europe Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.3.18.6. Rest of the Europe Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.3.18.7. Rest of the Europe Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. Nanomaterials In Personalized Medicine Key Manufacturers in Asia Pacific
- 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.4.4. APAC Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.4.5. APAC Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.4.6. APAC Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.4.7. APAC Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.4.8. APAC Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.4.9. China
- 12.4.9.1. Overview
- 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.9.3. China Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.4.9.4. China Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.4.9.5. China Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.4.9.6. China Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.4.9.7. China Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.4.10. India
- 12.4.10.1. Overview
- 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.10.3. India Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.4.10.4. India Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.4.10.5. India Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.4.10.6. India Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.4.10.7. India Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.4.11. Japan
- 12.4.11.1. Overview
- 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.11.3. Japan Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.4.11.4. Japan Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.4.11.5. Japan Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.4.11.6. Japan Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.4.11.7. Japan Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.4.12. South Korea
- 12.4.12.1. Overview
- 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.12.3. South Korea Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.4.12.4. South Korea Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.4.12.5. South Korea Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.4.12.6. South Korea Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.4.12.7. South Korea Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.4.13. Australia
- 12.4.13.1. Overview
- 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.13.3. Australia Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.4.13.4. Australia Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.4.13.5. Australia Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.4.13.6. Australia Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.4.13.7. Australia Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.4.14. Indonesia
- 12.4.14.1. Overview
- 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.14.3. Indonesia Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.4.14.4. Indonesia Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.4.14.5. Indonesia Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.4.14.6. Indonesia Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.4.14.7. Indonesia Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.4.15. Thailand
- 12.4.15.1. Overview
- 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.15.3. Thailand Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.4.15.4. Thailand Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.4.15.5. Thailand Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.4.15.6. Thailand Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.4.15.7. Thailand Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.4.16. Philippines
- 12.4.16.1. Overview
- 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.16.3. Philippines Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.4.16.4. Philippines Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.4.16.5. Philippines Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.4.16.6. Philippines Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.4.16.7. Philippines Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.4.17. Rest of APAC
- 12.4.17.1. Overview
- 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.17.3. Rest of APAC Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.4.17.4. Rest of APAC Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.4.17.5. Rest of APAC Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.4.17.6. Rest of APAC Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.4.17.7. Rest of APAC Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.5. Latin America (LATAM)
- 12.5.1. Overview
- 12.5.2. Nanomaterials In Personalized Medicine Key Manufacturers in Latin America
- 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.5.4. LATAM Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.5.5. LATAM Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.5.6. LATAM Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.5.7. LATAM Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.5.8. LATAM Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.5.9. Brazil
- 12.5.9.1. Overview
- 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.5.9.3. Brazil Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.5.9.4. Brazil Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.5.9.5. Brazil Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.5.9.6. Brazil Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.5.9.7. Brazil Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.5.10. Mexico
- 12.5.10.1. Overview
- 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.5.10.3. Mexico Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.5.10.4. Mexico Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.5.10.5. Mexico Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.5.10.6. Mexico Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.5.10.7. Mexico Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.5.11. Argentina
- 12.5.11.1. Overview
- 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.5.11.3. Argentina Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.5.11.4. Argentina Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.5.11.5. Argentina Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.5.11.6. Argentina Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.5.11.7. Argentina Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.5.12. Colombia
- 12.5.12.1. Overview
- 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.5.12.3. Colombia Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.5.12.4. Colombia Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.5.12.5. Colombia Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.5.12.6. Colombia Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.5.12.7. Colombia Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.5.13. Rest of LATAM
- 12.5.13.1. Overview
- 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.5.13.3. Rest of LATAM Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.5.13.4. Rest of LATAM Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.5.13.5. Rest of LATAM Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.5.13.6. Rest of LATAM Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.5.13.7. Rest of LATAM Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. Nanomaterials In Personalized Medicine Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.6.9. Saudi Arabia
- 12.6.9.1. Overview
- 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.6.9.3. Saudi Arabia Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.6.9.4. Saudi Arabia Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.6.9.5. Saudi Arabia Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.6.9.6. Saudi Arabia Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.6.9.7. Saudi Arabia Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.6.10. United Arab Emirates
- 12.6.10.1. Overview
- 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.6.10.3. United Arab Emirates Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.6.10.4. United Arab Emirates Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.6.10.5. United Arab Emirates Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.6.10.6. United Arab Emirates Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.6.10.7. United Arab Emirates Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.6.11. Israel
- 12.6.11.1. Overview
- 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.6.11.3. Israel Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.6.11.4. Israel Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.6.11.5. Israel Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.6.11.6. Israel Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.6.11.7. Israel Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.6.12. Turkey
- 12.6.12.1. Overview
- 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.6.12.3. Turkey Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.6.12.4. Turkey Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.6.12.5. Turkey Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.6.12.6. Turkey Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.6.12.7. Turkey Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.6.13. Algeria
- 12.6.13.1. Overview
- 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.6.13.3. Algeria Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.6.13.4. Algeria Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.6.13.5. Algeria Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.6.13.6. Algeria Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.6.13.7. Algeria Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.6.14. Egypt
- 12.6.14.1. Overview
- 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.6.14.3. Egypt Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.6.14.4. Egypt Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.6.14.5. Egypt Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.6.14.6. Egypt Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.6.14.7. Egypt Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 12.6.15. Rest of MEA
- 12.6.15.1. Overview
- 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.6.15.3. Rest of MEA Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
- 12.6.15.4. Rest of MEA Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
- 12.6.15.5. Rest of MEA Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
- 12.6.15.6. Rest of MEA Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
- 12.6.15.7. Rest of MEA Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
- 13. Key Vendor Analysis- Nanomaterials In Personalized Medicine Industry
- 13.1. Competitive Benchmarking
- 13.1.1. Competitive Dashboard
- 13.1.2. Competitive Positioning
- 13.2. Company Profiles
- 13.2.1. Merck KGaA Darmstadt Germany
- 13.2.2. OncoNano Medicine Inc.
- 13.2.3. Molecular Rebar Design Inc
- 13.2.4. Cello Therapeutics Inc.
- 13.2.5. Evonik Industries AG
- 13.2.6. Eisai Co. Ltd.
- 13.2.7. TÜV Rheinland AG
- 13.2.8. OCSiAl S.A
- 13.2.9. Sanofi S.A.
- 13.2.10. The Bristol-Myers Squibb Company
- 13.2.11. Thermo Fisher Scientific Inc.
- 13.2.12. Abbott Laboratories
- 13.2.13. American Elements Inc.
- 13.2.14. Pfizer & Co. Inc
- 13.2.15. BASF SE
- 13.2.16. Cour Pharmaceuticals Inc.
- 13.2.17. Nanocomposix Inc
- 13.2.18. NoPo Nanotechnologies Private Limited
- 13.2.19. Matexcel Biotech Inc.
- 13.2.20. Apurano Pharmaceuticals GmbH
- 13.2.21. SGN Nanopharma Inc.
- 13.2.22. Others
- 14. 360 Degree Analyst View
- 15. Appendix
- 15.1. Research Methodology
- 15.2. References
- 15.3. Abbreviations
- 15.4. Disclaimer
- 15.5. Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
